Company intelligence / Profile preview

InferMed

United Kingdom

Ownership: Private
Development stage: Other

Overview

InferMed was a UK-based clinical decision support and trial management software company founded in 1999 as a joint venture with Cancer Research UK. The company developed the MACRO EDC application and Arezzo decision support technology to assist clinicians in selecting appropriate treatment paths for patients and managing clinical trial data. InferMed has been acquired by Elsevier and is no longer an independent operating company.

Industry: Digital Health Medical Devices

Beyond the preview

Go deeper on InferMed.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on InferMed.

Explore the full profile